|
1011
|
Tdvax
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
MassBiologics
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1034
|
Tripedia
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1036
|
Td Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1037
|
Diphtheria and Tetanus Toxoids Adsorbed
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1063
|
Tripedia
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1078
|
Tdvax
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
MassBiologics
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1095
|
Tripedia
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur, Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1097
|
Td Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1098
|
Tetanus Toxoid Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1099
|
Diphtheria and Tetanus Toxoids Adsorbed
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1111
|
PBT
|
Botulism
|
Clostridium botulinum
|
Toxoid
|
Michigan Department of Public Health (MDPH)
|
Clinical - Discontinued
|
Subcutaneous
|
19837283
|
NA
|
|
1112
|
Bivalent (Equine)
|
Botulism
|
Clostridium botulinum
|
Toxoid
|
Sanofi Pasteur Limited
|
Approved
|
Intravenous
|
NA
|
NA
|
|
1113
|
BAT
|
Botulism
|
Clostridium botulinum
|
Toxoid
|
Cangene Corporation, a subsidiary of Emergent BioSolutions Inc.
|
Approved
|
Intravenous
|
NA
|
NA
|
|
1177
|
rAT and rLukS-PV
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Toxoid
|
Uniformed Services University of the Health Sciences
|
Clinical - Phase 1, Phase 2
|
NA
|
NA
|
NCT01011335
|
|
1231
|
ACAM-CDIFF
|
Clostridium Difficile Infection
|
Clostridium difficile
|
Toxoid
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00772343
|
|
1262
|
BR-TD-1001
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Boryung Biopharma Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
26091286
|
NCT04618939
|
|
1264
|
Ditanrix Adult
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
GlaxoSmithKline
|
Clinical - Phase 4
|
Intramuscular
|
NA
|
NCT01294605
|
|
1269
|
DTBIK
|
Diphtheria
|
Corynebacterium diphtheriae
|
Toxoid
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1284
|
DTBIK
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Toxoid
|
Mitsubishi Tanabe Pharma Corporation
|
Clinical - Phase 3
|
Subcutaneous
|
NA
|
NCT02118961
|
|
1303
|
Tetanus Monovalent vaccine
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Sanofi Pasteur, a Sanofi Company
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00928785
|
|
1308
|
BR-TD-1001
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Toxoid
|
Boryung Biopharma Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
26091286
|
NCT04618939
|